Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha-like 3 pseudogene

Molecular classification
Pseudogene, Processed pseudogene, Other
01

Overview

The eukaryotic translation elongation factor 1 alpha-like 3 pseudogene (ENSG00000250956) is a segment of human DNA that is homologous to the functional eukaryotic translation elongation factor 1 alpha genes but contains alterations such as disrupted coding sequences, loss of regulatory elements, or frameshift mutations that prevent it from encoding a functional protein product[1][4][5]. Pseudogenes like this may have arisen by gene duplication or retrotransposition but are typically regarded as non-functional "genomic fossils" and are not expressed as active proteins in the cell[4][5]. Although in rare cases some pseudogenes can be transcribed, or may have subtle regulatory effects, there is no evidence that ENSG00000250956 plays any direct role in disease, signaling, or cellular functions[1][4][5]. The precise nomenclature and classification are dictated by sequence homology rather than biological activity. This pseudogene is not considered a therapeutic or diagnostic target and is largely of interest for genomic annotation rather than functional biology or pharmacology[1][4].

02

Mechanism of action

None applicable.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

None reported—pseudogenes are not active drug targets; however, pseudogenes can sometimes complicate molecular studies (e.g., PCR bias)

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha-like 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha-like 3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call